Fostamatinib, marketed in the U.S. as TAVALISSE ® (fostamatinib disodium hexahydrate) tablets, is approved for the treatment of adult patients with chronic immune thrombocytopenia (ITP ...

an oral spleen tyrosine kinase inhibitor, for treating thrombocytopenia in adult patients with chronic ITP. This approval marks a significant expansion in Kissei’s market presence, providing a ...

Stimulating platelet production with romiplostim is an effective strategy for managing patients with ITP. Thrombocytopenias can be caused by increased platelet destruction, decreased platelet ...

Despite exhaustive medical interventions, bleeding diathesis and platelet counts worsened, so the patient underwent a splenectomy resulting in the resolution of the thrombocytopenia. Contributors The ...

The company’s commercialized products include Tavalisse, an oral spleen tyrosine kinase inhibitor for the treatment of adult patients with chronic immune thrombocytopenia; Rezlidhia, a non ...

Prognostic nutritional index as a predictor of cardiovascular and all-cause mortality in American adults with hypertension: results from the NHANES database ...

Severe fever with thrombocytopenia syndrome (SFTS ... 1103321 and 08067 were euthanized after 4 weeks of infection by overdose of pentobarbital sodium. Spleen, inguinal, axillary lymph node and bone ...